Invited Commentary: Navigating the Fog: Practical Use of Imaging to Guide HIPEC

References

• 1. Foster JM, Sleightholm R, Patel A, et al. Morbidity and Mortality Rates Following Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures. JAMA Netw Open 2019;2(1):e186847.
  Medline Google Scholar
• 2. Jafari MD, Halabi WJ, Stamos MJ, et al. Surgical Outcomes of Hyperthermic Intraperitoneal Chemotherapy: Analysis of the American College of Surgeons National Surgical Quality Improvement Program. JAMA Surg 2014;149(2):170–175.
  Medline Google Scholar
• 3. Newton AD, Bartlett EK, Karakousis GC. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Review of Factors Contributing to Morbidity and Mortality. J Gastrointest Oncol 2016;7(1):99–111.
  Medline Google Scholar
• 4. Srinivas Rao S, Baskaran NU, Cao J, et al. Imaging in Hyperthermic Intraperitoneal Chemotherapy. RadioGraphics 2025;45(5):e240124.
  Google Scholar
• 5. Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA. Predicting the Survival of Patients with Peritoneal Carcinomatosis of Colorectal Origin Treated by Aggressive Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Br J Surg 2004;91(6):739–746.
  Medline Google Scholar
• 6. Flicek K, Ashfaq A, Johnson CD, Menias C, Bagaria S, Wasif N. Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability? J Gastrointest Surg 2016;20(2):307–312.
  Medline Google Scholar